Skip to main content
. 2014 Nov;35(11):2140–2145. doi: 10.3174/ajnr.A4032

Table 4:

Clinical and imaging outcomes according to the presence/absence of a subarachnoid hemorrhage at presentation

Variable Total (No.) (%) Unruptured (No.) (%) Ruptured (No.) (%) P Value
Clinical outcomes
    Total treatments 93 81 (87) 12 (13)
    Mortality 0 0 (0) 0 (0) 1.000
    Morbidity 4 (4) 3 (3) 1 (8) .430
        Infarction 3 (3) 2 (2) 1 (8) .343
        Hydrocephalus 1 (1) 1 (1) 0 (0) 1.000
Visual outcomes
    Total patients 65 54 (83) 11 (17)
    Visual disturbance at presentation 22 (34) 21 (39) 1 (9) .082
    Visual disturbance after treatment .03
        Improved 15 (68) 15 (71) 0 (0)
        Unchanged 5 (22) 4 (27) 1 (100)
        Worse 2 (9) 2 (9) 0 (0)
        New (% of all patients) 1 (2) 0 (0) 1 (9)
Imaging outcomes
    Aneurysms 65 53 (82) 12 (18)
        Primary occlusion 35 (55) 30 (58) 5 (42) .523
    Aneurysms with >12 months' follow-up 53 45 8 .211
        Retreatment 16 (30) 10 (22) 6 (75) .0007a
        Progressive occlusion 2 (4) 2 (4) 0 (0)
        Unchanged 34 (64) 33 (73) 2 (25)
a

Retreatment-versus-progressive occlusion/unchanged.